Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion

Cancer Genet Cytogenet. 2004 Jul 15;152(2):177-8. doi: 10.1016/j.cancergencyto.2003.12.002.

Authors

José L Vizmanos, María J Larráyoz, Iria Vázquez, María D Odero, Roberto Hernández, Idoya Lahortiga, Francisco J Novo, María T Ardanaz, María J Calasanz

PMID: 15262444
DOI: 10.1016/j.cancergencyto.2003.12.002

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antineoplastic Agents, Phytogenic / adverse effects*
Bone Marrow Transplantation
Chromosome Banding
Chromosomes, Human, Pair 16 / genetics*
Chromosomes, Human, Pair 8 / genetics*
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Monocytic, Acute / chemically induced
Leukemia, Monocytic, Acute / genetics
Leukemia, Monocytic, Acute / therapy*
Male
Oncogene Proteins, Fusion / genetics*
Podophyllotoxin / adverse effects*
Remission Induction
Translocation, Genetic / genetics*

Substances

Antineoplastic Agents, Phytogenic
MOZ-CBP fusion protein, human
Oncogene Proteins, Fusion
Podophyllotoxin